208 related articles for article (PubMed ID: 16336324)
21. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
Inskip PD
Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
[TBL] [Abstract][Full Text] [Related]
22. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
Rabbani F; Russo P
Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
[TBL] [Abstract][Full Text] [Related]
23. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
24. [Renal cell carcinoma in Iceland].
Thoroddsen A; Einarsson GV; Gudbjartsson T
Laeknabladid; 2007 Apr; 93(4):283-97. PubMed ID: 17460340
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer is not increased in men with vasectomy in denmark.
Lynge E
J Urol; 2002 Aug; 168(2):488-90. PubMed ID: 12131294
[TBL] [Abstract][Full Text] [Related]
26. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.
Ahmed F; Goodman MT; Kosary C; Ruiz B; Wu XC; Chen VW; Correa CN
Cancer; 2006 Sep; 107(5 Suppl):1162-71. PubMed ID: 16838312
[TBL] [Abstract][Full Text] [Related]
27. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
28. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
29. Second primary malignancies associated with renal cell carcinoma histological subtypes.
Thompson RH; Leibovich BC; Cheville JC; Webster WS; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):900-3; discussion 903-4. PubMed ID: 16890648
[TBL] [Abstract][Full Text] [Related]
30. Association between colorectal cancer and urologic cancers.
Calderwood AH; Huo D; Rubin DT
Arch Intern Med; 2008 May; 168(9):1003-9. PubMed ID: 18474765
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma and end stage renal disease.
Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
[TBL] [Abstract][Full Text] [Related]
32. Improving overall men's health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease.
Moyad MA
Urol Oncol; 2004; 22(6):485-9. PubMed ID: 15610866
[TBL] [Abstract][Full Text] [Related]
33. Review of potential risk factors for kidney (renal cell) cancer.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):280-93. PubMed ID: 11769880
[TBL] [Abstract][Full Text] [Related]
34. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of patients diagnosed with both melanoma and renal cell cancer.
Abern MR; Tsivian M; Coogan CL; Kaufman HL; Polascik TJ
Cancer Causes Control; 2013 Nov; 24(11):1925-33. PubMed ID: 23897487
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features of urological malignancies with paraneoplastic syndromes].
Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815
[TBL] [Abstract][Full Text] [Related]
37. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.
Chen T; Fallah M; Sundquist K; Liu H; Hemminki K
Eur J Cancer; 2014 Aug; 50(12):2108-18. PubMed ID: 24923229
[TBL] [Abstract][Full Text] [Related]
38. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
39. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
Rabbani F; Reuter VE; Katz J; Russo P
Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
[TBL] [Abstract][Full Text] [Related]
40. Family history of cancer and the risk of renal cell cancer.
Negri E; Foschi R; Talamini R; Montella M; Ramazzotti V; Dal Maso L; Bosetti C; Franceschi S; Zucchetto A; La Vecchia C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2441-4. PubMed ID: 17164368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
